Browse Related Topics For:

Pharmaceutical Industry

928
Prescription Drugs
850
FDA
842
Patents
590
Pharmaceutical Patents
517
Patent Litigation
484
Generic Drugs
405
Patent Infringement
348
Medical Devices
306
Biosimilars
299
Healthcare
267
ANDA
211
Biotechnology
204
SCOTUS
177
Hatch-Waxman
177
Manufacturers
170
Popular
149
FTC
147
BPCIA
142
Off-Label Promotion
138
Drug Pricing
135
CMS
135
HHS
133
Biologics
131
Health Care Providers
131
Medicare
131
Pharmacies
120
Life Sciences
119
Physicians
116
Affordable Care Act
116
Medicaid
115
China
108
DOJ
105
EU
102
Hospitals
100
Section 340B
99
FDCA
98
False Claims Act (FCA)
96
Sandoz
93
First Amendment
91
Clinical Trials
89
Amgen
85
Off-Label Use
85
Teva Pharmaceuticals
84
Compliance
81
Enforcement Actions
79
Claim Construction
79
Mylan Pharmaceuticals
79
Preemption
79
SEC
78
Appeals
78
Class Action
77
FDA Approval
77
Labeling
76
Sandoz v Amgen
73
HRSA
72
Actavis Inc.
68
Antitrust Litigation
68
OIG
67
FCPA
67
Reverse Payment Settlement Agreements
66
Inter Partes Review (IPR) Proceeding
66
Marketing
64
Corporate Counsel
64
Novartis
63
Pay-For-Delay
63
Pfizer
63
USPTO
62
Failure To Warn
62
Patent Trial and Appeal Board
62
Patent-in-Suit
61
FTC v Actavis
59
GlaxoSmithKline
59
Sunshine Act
58
Draft Guidance
57
Patent-Eligible Subject Matter
57
UK
56
Obviousness
55
Teva v Sandoz
54
Bribery
52
Settlement
50
Anti-Kickback Statute
50
Australia
50
Preliminary Injunctions
49
De Novo Standard of Review
48
Advertising
48
Apotex
48
Clear Error Standard
47
Amarin
47
Civil Monetary Penalty
47
Federal Rules of Civil Procedure
47
Infringement
47
Whistleblowers
46
Medical Research
46
Reporting Requirements
45
Medicare Part D
45
Orphan Drugs
44
AstraZeneca
44
Free Speech
43
Prior Art
42
Health Insurance
42
Patent Applications
42
PHRMA
42
Warning Labels
40
Disclosure Requirements
39
Comment Period
39
Research and Development
38
21st Century Cures Initiative
38
Bayer
38
Fraud
38
Merck
37
Misbranding
36
Covered Entities
36
Personal Jurisdiction
35
Criminal Prosecution
35
Final Rules
35
Patent Dance
35
Summary Judgment
34
AbbVie
34
Financial Sector
34
Mergers
33
Drug Safety
33
Legislative Agendas
33
Trump Administration
32
Drug Compounding
32
Hart-Scott-Rodino Act
32
Multidistrict Litigation
32
Negligence
31
Acquisitions
31
Eli Lilly
31
Intellectual Property Protection
31
Opioid
30
Antitrust Provisions
30
Competition
30
Design Defects
30
Enforcement
30
Pending Legislation
30
Qui Tam
30
Sherman Act
29
America Invents Act
29
Causation
29
Healthcare Reform
29
Johnson & Johnson
29
Proposed Legislation
29
Proposed Regulation
29
Trademarks
29
White Collar Crimes
28
Canada
28
Commercial Marketing
28
Commercial Speech
28
Declaratory Judgments
28
Healthcare Facilities
28
Kickbacks
28
Patent Invalidity
27
Anti-Corruption
27
Dismissals
27
DNA
27
Jurisdiction
27
Product Labels
27
Watson Pharmaceuticals
26
Abbott Laboratories
26
Anti-Competitive
26
Cancer
26
EPA
26
GPOs
26
NIH
26
Notice Requirements
26
Product Defects
25
False Advertising
25
HIPAA
25
Innovation
25
Learned Intermediary
25
Safe Harbors
25
Transparency
24
Bristol-Myers Squibb
24
Expert Testimony
24
Hospira
24
Insurance Industry
24
Motion to Dismiss
23
Biologics Price Competition and Innovation Act of 2009
23
Corruption
23
Drug & Alcohol Abuse
23
Product Hopping
23
Public Health
22
Allergan Inc
22
Financial Markets
22
Gilead Sciences
22
Healthcare Fraud
22
Mental Health
22
New Guidance
22
PLIVA v Mensing
21
Antitrust Violations
21
European Commission
21
Insider Trading
21
Janssen Pharmaceuticals
21
Standing
20
Class Certification
20
DaimlerChrysler v Bauman
20
Discovery
20
Hazardous Waste
20
Licenses
20
Medicare Part B
20
New Legislation
20
Public Comment
20
Regulatory Standards
20
Trans-Pacific Partnership
19
Birth Defects
19
DEA
19
Disgorgement
19
FFDCA
19
Imports
19
Patent Reform
19
Patients
19
Pleading Standards
19
Russia
19
Scientific Research
18
aBLA
18
License Agreements
18
Mutual Pharmaceuticals v Bartlett
18
Professional Conferences
18
Regulatory Oversight
18
Securities Fraud
18
Social Media
18
Takeda Pharmaceuticals
18
Valeant
18
Wrongful Death
17
Audits
17
Chief Compliance Officers
17
Ethics
17
Lanham Act
17
Misrepresentation
17
Omnicare
17
Prescription Drug Coverage
17
Public Health Service Act
17
RCRA
16
Attorney Generals
16
Barack Obama
16
Biopharmaceutical
16
Caronia
16
Citizen Petitions
16
Cybersecurity
16
Hedge Funds
16
India
16
Intellectual Property Litigation
16
Orange Book
16
Side Effects
16
Technology
16
Technology Sector
16
Trade Secrets
16
UK Brexit
16
Warner Chilcott
15
AMP v Myriad
15
Antitrust Investigations
15
Cephalon
15
Damages
15
Final Guidance
15
France
15
Innovator Liability
15
Mayo v. Prometheus
15
Medical Malpractice
15
Myriad
15
Open Payments
15
Penalties
15
Price-Fixing
15
Stocks
15
Strict Liability
15
Unfair Competition
14
Congressional Investigations & Hearings
14
Data Protection
14
Duty to Warn
14
European Medicines Agency (EMA)
14
Exports
14
Genetic Materials
14
Government Investigations
14
Monopolization
14
Securities
14
Securities Litigation
14
Wyeth
14
Yates Memorandum
13
Administrative Procedure Act
13
Automotive Industry
13
CA Supreme Court
13
CAFA
13
Cartels
13
Certiorari
13
Copyright
13
DSCSA
13
Evidence
13
Expert Witness
13
Fee-for-Service
13
Medicare Advantage
13
OMB
13
Omnicare v Laborers District Council
13
Par Pharmaceutical
13
Personalized Medicine
13
Post-Grant Review
13
Pregnancy
13
Product Exclusivity
13
Professional Misconduct
13
Relators
13
Section 11
13
Specific Jurisdiction
13
Substance Abuse
13
Supply Chain
13
Trade Agreements
13
Wells Fargo
12
Banks
12
Breach of Contract
12
Controlled Substances
12
Distributors
12
DQSA
12
Genentech
12
Induced Infringement
12
Mass Tort Litigation
12
Oil & Gas
12
Putative Class Actions
12
Regulatory Agenda
12
Social Networks
12
Telemedicine
12
Venture Capital
12
World Health Organization
11
Banking Sector
11
Co-payments
11
Diagnostic Tests
11
Dietary Supplements
11
Drug Approvals
11
Endo Pharmaceuticals
11
Foreign Corporations
11
Foreign Investment
11
General Jurisdiction
11
Generic
11
Inadequate Warning
11
Injunctive Relief
11
IP License
11
Joint Venture
11
Manufacturing Defects
11
Material Misstatements
11
MCOs
11
Medtronic
11
Misleading Statements
11
Nexium
11
On-Sale Bar
11
Payment Records
11
Private Equity
11
REMS
11
Retailers
11
Securities Act of 1933
11
Settlement Agreements
11
Software
11
Startups
11
Teaching Hospitals
11
Ukraine
11
Wholesale
11
Young Lawyers
10
21st Century Cures Act
10
3D Printing
10
Arbitration
10
Breach of Warranty
10
CDC
10
DOL
10
Drug Distribution
10
En Banc Review
10
Energy Sector
10
Exclusivity
10
Federal Contractors
10
Financial Conduct Authority (FCA)
10
Fraudulent Joinder
10
GAO
10
Genzyme
10
Human Genes
10
Injunctions
10
Japan
10
Medical Supplies
10
Ministry of Health
10
Nurses
10
OFAC
10
Otsuka Pharmaceutical
10
OxyContin
10
Patent Term Adjustment
10
Petition for Writ of Certiorari
10
Physician Medicare Reimbursements
10
Presidential Elections
10
Public Disclosure
10
Publicly-Traded Companies
10
Rebates
10
Registration Statement
10
Sanctions
10
Sanofi-Aventis
10
Subject Matter Jurisdiction
10
UK Competition and Markets Authority (CMA)
10
Warning Letters
9
Brand
9
Chemicals
9
CHIP
9
Competition Authorities
9
Continuing Medical Education
9
Controlled Substances Act
9
Defense Strategies
9
Department of Health
9
Durable Medical Equipment
9
Federal Funding
9
Financial Institutions
9
Food Manufacturers
9
Forum Shopping
9
Google
9
Healthcare Costs
9
Illegal Drugs
9
Informed Consent
9
Managed Care Contracts
9
Medicaid Expansion
9
Mexico
9
Omnibus Guidance
9
PHI
9
Physician Payments
9
Private Right of Action
9
RanBaxy
9
Registration Requirement
9
Reverse Payments
9
RICO
9
Rule-of-Reason Analysis
9
Rulemaking Process
9
Securities Exchange Act
9
Shareholder Litigation
9
Shareholders
9
Strategic Enforcement Plan
9
Vaccinations
9
Websites
9
Zoloft
8
Adverse Events
8
Brazil
8
BRCA
8
Clinical Laboratories
8
CLS Bank v Alice Corp
8
Corporate Culture
8
Corporate Integrity Agreement
8
Data Collection
8
Daubert Standards
8
Deferred Prosecution Agreements
8
Employee Benefits
8
Fiduciary Duty
8
FINRA
8
First-to-File
8
FOIA
8
Genetic Testing
8
Good Faith
8
Health Information Technologies
8
Interpretive Rule
8
Inventors
8
Investors
8
Italy
8
Joinder
8
Legislative Committees
8
Long Term Care Facilities
8
MedPAC
8
Merger Agreements
8
Multinationals
8
Noninfringement
8
PHSA
8
Product Recalls
8
Public Meetings
8
Reimbursements
8
Risk Assessment
8
Roxane Laboratories
8
Royalties
8
Safe Drug Disposal
8
Scienter
8
Standard of Review
8
Stark Law
8
Tax Credits
8
Unfair or Deceptive Trade Practices
8
USDA
8
Written Descriptions
8
WTO
7
Administrative Proceedings
7
Antitrust Division
7
Aviation Industry
7
Bank Accounts
7
Boehringer
7
Burden of Proof
7
C-Suite Executives
7
CFDA
7
Confidential Information
7
Due Diligence
7
Environmental Policies
7
Export Controls
7
False Statements
7
Federal Budget
7
Food Labeling
7
Germany
7
Guidance Update
7
Hackers
7
Hiring & Firing
7
Home Health Care
7
Innovation Act
7
Internal Controls
7
Inventions
7
Ireland
7
IRS
7
Jazz Pharmaceuticals
7
Jury Verdicts
7
Monsanto
7
Myriad-Mayo
7
New Regulations
7
Nursing Homes
7
Pain Management
7
Patient Assistance Programs
7
Permanent Injunctions
7
Premerger Notifications
7
Public Hearing
7
Public Offerings
7
Punitive Damages
7
Recordkeeping Requirements
7
Remand
7
Repeal
7
Risk Management
7
RMBS
7
Securities Violations
7
Statute of Limitations
7
Third-Party
7
Trademark Infringement
7
TRIPS Agreement
6
ACOs
6
Africa
6
Agricultural Sector
6
AIDS
6
Allergan v Sandoz
6
Anti-Bribery
6
Anti-Monopoly
6
Attorney-Client Privilege
6
Bayh-Dole Act
6
Bonds
6
Celebrity Endorsements
6
Choice-of-Law
6
Compensatory Damages
6
Corporate Taxes
6
Cosmetics
6
Cost-Sharing
6
Covered Recipients
6
Cross-Border Transactions
6
Cyber Attacks
6
Data Breach
6
Data-Sharing
6
Declaratory Relief
6
Diagnostic Method
6
EEA
6
Emerging Growth Companies
6
Exclusive Dealing Agreements
6
Federal Register
6
Fines
6
Foreign Official
6
Forest Laboratories
6
Forum
6
Funding
6
Health Insurance Exchanges
6
Hoffman LaRoche
6
Initial Public Offerings
6
International Harmonization
6
Inversion
6
Investment
6
Lipitor
6
Litigation Strategies
6
Martin Shkreli
6
Meals-Gifts-and Entertainment Rules
6
Medical Marijuana
6
Mobile Apps
6
Negligent Misrepresentation
6
Negotiations
6
New Zealand
6
Obama Administration
6
OCR
6
OECD
6
Over-the-Counter Sales
6
Patent Term Extensions
6
Patent Trolls
6
Patient Privacy Rights
6
Pharmaceutical Reverse Distributors
6
Pleadings
6
Provider Payments
6
Public Health Insurance Marketplace
6
Radiopharmaceuticals
6
Real Party in Interest
6
Samsung
6
SFDA
6
Skilled Nursing Facility
6
Standard Essential Patents
6
Statement of Opinion
6
Subpoenas
6
Suppliers
6
TCPA
6
Telecommunications
6
The Clayton Act
6
Theranos
6
Twombly/Iqbal Pleading Standard
6
Unions
6
Vacated
6
Value-Based Purchasing
6
Yahoo!
5
Abuse of Dominance
5
Abuse of Process
5
American Medical Association
5
Applications
5
Attorney's Fees
5
Australian Patent Office
5
Auto Manufacturers
5
Big Data
5
Biogen Idec
5
BIS
5
Black Box Warnings
5
Board of Directors
5
Celltrion
5
China FDA
5
Cipro
5
Classen Immunotherapies
5
Competition Act
5
Conflicts of Interest
5
Conspiracies
5
Construction Industry
5
Consumer Fraud
5
Consumer Lenders
5
Criminal Conspiracy
5
Cross-Border
5
Cross-Selling
5
CVS
5
Data Security
5
Databases
5
Digital Health
5
Direct Infringement
5
Discount Pricing
5
Dispute Resolution
5
Diversity Jurisdiction
5
Domestic Violence
5
Dormant Commerce Clause
5
E-Commerce
5
Employer Group Health Plans
5
Enablement Inquiries
5
Facebook
5
FBI
5
FDA Warning Letters
5
Federal Jurisdiction
5
Federal Rule 12(b)(6)
5
Fiduciary Rule
5
Fifth Amendment
5
Food Safety
5
Foreign Manufacturers
5
General Motors
5
HCEI
5
Interchangeability
5
Interest Rate Adjustments
5
International Arbitration
5
Internet
5
IPO
5
JPMorgan Chase
5
Jury Instructions
5
Kaiser Permanente
5
Kim Kardashian
5
Licensing Rules
5
Likelihood of Confusion
5
Limelight v Akamai
5
Marketing Authorization Application
5
Medical Reimbursement
5
Member State
5
Mensing
5
Merger Controls
5
Method Claims
5
Mortgages
5
Motion for Summary Judgment
5
No-AG Agreement
5
Online Advertisements
5
Online Marketplace Lending
5
OPDP
5
Outsourcing
5
Overpayment
5
PATENT Act
5
Patent Prosecution
5
Prior Express Consent
5
PSLRA
5
Referendums
5
Removal
5
Reversal
5
Sanofi
5
Secretary of HHS
5
Section 10(b)
5
Section 101
5
Shire Development v Watson
5
Small Business
5
Software Developers
5
Solicitor General
5
South Korea
5
Subsidies
5
Tariffs
5
Telehealth
5
Trade Agreements Act
5
Trade Relations
5
Trademark Trial and Appeal Board
5
Twitter
5
UK Bribery Act
5
Vendors
5
Veterinary Products
5
Volkswagen
5
Wage and Hour
5
Walgreens
4
Acquittals
4
Actos
4
Admissible Evidence
4
Advisory Committee
4
Aerospace
4
ALJ
4
Alzheimer's
4
Amended Legislation
4
Amicus Briefs
4
Antibiotics
4
Anticompetitive Behavior
4
Antitrust Conspiracies
4
Antitrust Injuries
4
Apple
4
Applicable Manufacturers
4
Article III
4
Ascertainable Class
4
Asia
4
Australian Competition and Consumer Commission
4
Australian Medical Association
4
Ballot Measures
4
Cardinal Health
4
CEOs
4
CETA
4
CGMP
4
Chevron Deference
4
Code of Conduct
4
Commerce Clause
4
Commercial Bankruptcy
4
Compulsory Licenses
4
Consent Order
4
Contraceptives
4
Cooperation
4
Corporate Governance
4
Daiichi Sankyo
4
Dairy Farmers
4
Daubert Ruling
4
Department of Transportation (DOT)
4
Department of Veterans Affairs
4
Derivative Suit
4
Deutsche Bank
4
Disclosure
4
DMEPOS
4
Double Patent
4
Duty of Care
4
Duty to Deal
4
Economic Development
4
EHR
4
Elan Pharmaceuticals
4
Elder Abuse
4
ERISA
4
EU-US Privacy Shield
4
Exemptions
4
Failure To Disclose
4
FCC
4
FD&C Act
4
FDASIA
4
Federal Pilot Programs
4
Food Recalls
4
Forum Non Conveniens
4
FRAND
4
Fraud and Abuse
4
Fresenius
4
FTC Act
4
General Electric
4
Global Marketplace
4
Guilty Pleas
4
Hazardous Substances
4
Hepatitis C
4
HITECH
4
HIV
4
Hospice
4
Hospital Mergers
4
Human Rights
4
Information Technology
4
Inspections
4
Interest Rates
4
Interlocutory Injunctions
4
InterMune
4
Investigational New Drug Application (IND)
4
Investigational New Drug procedures (IND)
4
Iran
4
ITC
4
JAMA
4
Job Creation
4
Kimble v Marvel Enterprises
4
License Applications
4
Local Ordinance
4
Marijuana
4
Material Nonpublic Information
4
Medicaid Reimbursements
4
Medical Records
4
Microsoft
4
Middle East
4
Minimum Contacts
4
Mining
4
Misleading Impressions
4
Mootness
4
NAFTA
4
National Cancer Moonshot
4
NDRC
4
Non-Prosecution Agreements
4
Nutritional Supplements
4
Patent Portfolios
4
Patient Safety
4
PDUFA
4
Pension Funds
4
Pensions
4
Personal Liability
4
Pharmaceutical Distribution
4
Pharmacist
4
Pre-Merger Filing Requirements
4
Prejudgment Interest
4
Premiums
4
Price Gouging
4
Privacy Laws
4
Proposed Amendments
4
Proximate Cause
4
Quality Control Plan
4
Regulatory Agencies
4
Remedies
4
Retirement Plan
4
Rule 9(b)
4
SDN List
4
Sealed Records
4
Section 2
4
Shareholder Activism
4
Shipping
4
SmithKline Beecham
4
Social Services
4
Solid Waste
4
State and Local Government
4
Stem cells
4
STRONG Patents Act
4
Surveys
4
The Common Rule
4
Third-Party Relationships
4
Toxic Exposure
4
Trademark Litigation
4
Trademark Registration
4
Training
4
Transportation Industry
4
TTIP
4
UAW
4
Universities
4
USTR
4
Viagra
4
Whistleblower Protection Policies
3
23andMe
3
510(k) RTA
3
Acquisition Agreements
3
Administrative Authority
3
Algorithmic Trading
3
Ambry
3
Amended Regulation
3
Animal Testing
3
Annual Reports
3
Anti-SLAPP
3
Anticompetitive Agreements
3
Asbestos
3
AZ Supreme Court
3
Bank of America
3
Barclays
3
Best Practices
3
Biometric Information
3
Bodily Injury
3
Brokers
3
Cadence Pharmaceuticals Inc.
3
Cadillac Tax
3
CAFC
3
Calculation of Damages
3
Capital Raising
3
Cease and Desist Orders
3
CFPB
3
Charles Grassley
3
Clear and Convincing Evidence
3
CMMI
3
Collective Bargaining
3
Columbia
3
Comcast v. Behrend
3
Commercial General Liability Policies
3
Confidentiality Agreements
3
Congressional Committees
3
Consent
3
Consumer Product Safety Commission (CPSC)
3
Consumer Protection Act
3
Contraceptive Coverage Mandate
3
Contract Disputes
3
Conversion
3
Corporate Crimes
3
Corporate Misconduct
3
Counterclaims
3
Counterfeit Drugs
3
Country of Origin
3
Coupons
3
Covered Business Method Patents
3
Criminal Investigations
3
Cuba
3
Customs
3
Data Privacy
3
Daubert Hearing
3
DE Supreme Court
3
Defense Sector
3
DHS
3
Disciplinary Proceedings
3
Discounts
3
Dismissal With Prejudice
3
Divestiture
3
Doctrine of Equivalents
3
Dodd-Frank
3
Drug Testing
3
Drug Wholesaling
3
Due Process
3
E-Cigarettes
3
EAR
3
Ebola
3
EEOC
3
EFTA
3
End-of-Life-Care
3
Entrepreneurs
3
Essential Drug List
3
EU Single Market
3
European Court of Justice (ECJ)
3
Executive Compensation
3
Expectation Damages
3
Failure To State A Claim
3
Fair Work Commission
3
False Press Release
3
Federal Supply Schedule (FSS)
3
Fee-Shifting
3
Financial Crisis
3
FinTech
3
First-to-Invent
3
Food and Drug Administration Amendments Act (FDAAA)
3
Foreign Subsidiaries
3
Form 10-K
3
Form 8-K
3
Genetic Markers
3
Global Economy
3
Goldman Sachs
3
Good Clinical Practices
3
Government Contractors
3
Governor Baker
3
Halliburton
3
Health Canada
3
Health Safety
3
Health Savings Accounts
3
Healthcare.gov
3
Human Genome Project
3
Implied Warranties
3
Income Taxes
3
Individual Accountability
3
Individual Mandate
3
Inducements
3
Influenza
3
Inter Partes Reexamination
3
Internal Investigations
3
International Data Transfers
3
Interstate Commerce
3
Investigations
3
Investment Banks
3
IRB
3
Irreparable Harm
3
Judicial Review
3
Jury Awards
3
Laboratory Developed Tests
3
Law Enforcement
3
Litigation Hold
3
Lyft
3
Market Manipulation
3
Markman Hearing
3
Media
3
Medicaid Reform
3
Medical Equipment
3
Medicare Access and CHIP Reauthorization (MACRA)
3
Medicare Modernization Act
3
Medicines and Healthcare Products Regulatory Agency (MHRA)
3
Mental Health Parity Rule
3
Merrill Lynch
3
Minority Shareholders
3
Mobile Devices
3
MOFCOM
3
Money Laundering
3
Motion for Reconsideration
3
Motion To Strike
3
Nanomaterials
3
Nanotechnology
3
National Emissions Standards
3
Native American Issues
3
Nautilus Inc. v. Biosig Instruments
3
Negligence Per Se
3
Nike
3
NJ Supreme Court
3
Non-Disclosure Agreement
3
Non-Public Information
3
Notice Provisions
3
Numerosity
3
Online Drug Sales
3
openFDA
3
OPPS